Member of Lyonbiopole
Development of antivirals for HIV and EBV infections. Main objective is the control of the HIV-1 reservoir allowing a functional cure with cessation of the antiretroviral therapy. The second objective is the prevention of EBV-induced post transplant lymphoproliferative diseases.
Strategic application domain: Human Medicine
Application market: Hematology, Infectious Diseases, Oncology
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Small Molecules
Created on oct. 9th, 2020 - 2 employees
Address
321 avenue Tony Garnier 69007 Lyon
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.